Clinical Trial Update: First-Time-in-Human Study of GSK5471713 in Adults With mCRPC [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the first-time-in-human study of GSK5471713 in adults with metastatic castration-resistant prostate cancer, a Phase 1/Phase 2 t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• GSK5471713

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Prostate | Phase 1, Phase 2 | Status: RECRUITING